CTech's Tuesday Roundup of Israeli Tech News
Softbank invests additional $200 million in Cybereason; Rivals' earning reports should have Teva's shareholders worried
CTech : 2019-08-06T13:59:38..
Softbank invests additional $200 million in Cybereason. The Japanese telecommunication corporation has now invested more than $350 million in the Israeli cyber company. Read more
IFF uncovers bribes involving Frutarom, former CEO may be involved. Though IFF did not name any of the suspects involved, Frutarom's former CEO and president Ori Yehudai is one of them, according to one person familiar with the matter. Read moreAnalysis | Rivals' earning reports should have Teva's shareholders worried. Teva’s leadership will break its self-imposed silence on Wednesday when the company publishes its second-quarter report for 2019. Read more Read more Israeli universities continue to fall in global rankings. Of the nine Israeli institutions that made it into the Center for World University Rankings’ (CWUR) top 2000 universities list, four universities were ranked lower than 2018’s ranking, with Tel Aviv University getting kicked out of the top 100 list. Read more Seedo to offer consumer leasing on home cannabis farming device. Seedo develops an automated device approximately the size of a mini-fridge for farming cannabis at home under controlled conditions. Read more Beresheet may have unleashed a horde of water bears on the moon, report says. The crashed Israeli spacecraft was carrying a DNA bank containing 30 million pages of information, human DNA samples, and thousands of tardigrades, microscopic creatures better known as water bears, WIRED magazine reported. Read more Medtech company CSI acquires assets of Israeli company Gardia for $17 million. The assets in question are Gardia's WIRION system, which helps reduce complications during minimally invasive interventional procedures. Read more QualiTest co-founder partners with cannabis company Intelicanna on cannabis review website. The assets in question are Gardia's WIRION system, which helps reduce complications during minimally invasive interventional procedures. Read more ALS drug developer NeuroSense crowdfunds $1.15 million. The company’s 1,114 new investors will jointly own a 10% stake, the company said. Read more